(Tradingsat.com) – EOS imaging announced Monday the approval of the Food and Drug Administration (FDA) for hipEOS 3D planning software for hip replacement surgery based on the system of stereoradiography 2D / 3D group.
“hipEOS is the first offer of a range of software to be associated with the EOS imaging system,” recalls the pioneer in the field of orthopedic medical imaging 2D / 3D.
Developed by OneFit medical, company EOS imaging group, it allows surgeons to perform, based on images of stereoradiography 2D / 3D low dose planning a prosthetic surgery hip and in particular to choose the position size, and check the expected recovery.
Read also
The software uses the full size image without using projection and 3D anatomical parameters of the patient from the EOS exam. hipEOS has obtained the CE mark in March 2014.
“hipEOS marks the first step in our rich content of the operating strategy of the images obtained with the system stereoradiography 2D / 3D EOS”. [...] .dropoff Window We welcome this authorization on the market in the United States, which allows us to expand to the US, current and future users, this software package that has been very well received at its launch at the Congress the French Society of Orthopaedic Surgery and Traumatology (SOFCOT) in November, “said Marie Meynadier, CEO of EOS imaging.
Warning! Receive our” push notifications “real-time information on every EOS IMAGING through our Application TradingSat Exchange
You follow this action Get all information in real time.
PL – © 2014 Tradingsat.com
No comments:
Post a Comment